Akdital · CSEMA:AKT
Akdital — Investor Presentation (June 2023)
36 slides from Akdital's investor presentation, June 2023
Slide 1: Investor Presentation June 2023
Investor Presentation June 2023
Slide 2: Summary
SUMMARY AKDITAL Operational Photo library presentation & financial performance Healthcare Outlook & Appendices sector in strategic Morocco priorities 2
Slide 3: AKDITAL presentation
AKDITAL presentation Investor Presentation - June 2023 3
Slide 4: Key Figures
KEY FIGURES AKDITAL, the private healthcare leader in the MENA region 21 2 192 15% 4 230 Clinics Beds Of private bed capacity Employees, of whom in Morocco 66% paramedical staff 1 558 4 Md MAD 1.03 billion MAD 216 493 Doctors Market Cap Revenue Number of admissions In 2022 in 2022 Investor Presentat
Slide 5: Company history and openings of new facilities
Opening of 2 new facilities with a total capacity of 220 beds Acquisition of the Vinci and Atfal clinics with a total Opening of 3 new facilites in capacity of 92 beds Casablanca (Casablanca International Oncology Center, Opening of 4 new facilities Expansion of Casablanca Private Hospital & providi
Slide 6: Cities, bed capacity, clinics and revenue growth
N° of cities N° of clinics Bed capacity Revenue 8 2.192 21 2.000 1.822 CAGR 6 17 68% 1.034 9 912 768 600 600 2 507 5 5 325 1 1 1 2 200 147 2018 2019 2020 2021 2022 2023 2018 2019 2020 2021 2022 2023 2018 2019 2020 2021 2022 2023 2018 2019 2020 2021 2022 2023 Investor Presentation - June 2023 6
Slide 7: Clinic network map and bed capacity by city
Tangier 8 Casablanca – 892 beds Fès Jerrada (100) Longchamps (50) Mohammédia Ain Borja (100) Da Vinci (42) Casablanca Salé CIOC (150) Sidi Maârouf (100) HPC (200) Bouskoura (100) El Jadida Atfal (50) Safi 2 El Jadida – 220 beds 2 Salé – 220 beds Oncology Center Oncology Center
Slide 8: Clinics: opening year and bed capacity
International Oncology Center Medical and Surgical Clinic Jerrada Oasis Clinic Casablanca Ain Borja Clinic Casablanca Longchamps Opening year : 2011 Opening year : 2018 Opening year : 2019 Opening year : 2019 Bed capacity : 100 beds Bed capacity : 100 beds Bed capacity : 150 beds Bed capacity : 50 b
Slide 9: Clinics opened 2022-2023 and bed capacity
Private Hospital & the International Private Hospital & the International Private Hospital & the International Panorama clinic Sidi Maarouf Oncology Center of Agadir Oncology Center of Tangier Oncology Center of Salé Opening year : 2022 Opening year : 2022 Opening year : 2022 Opening year : 2022 Be
Slide 10: Ethics, people, environment and quality commitments
A robust ethics and compliance system Professional conduct & ethics code put in place Corruption Prevention Procedure Women and men, pillars of Akdital's HSE investments to reinforce safety development in our facilities Large training budgets Implementation of equipment, controls and process
Slide 11: Healthcare sector in Morocco
Healthcare sector in Morocco Investor Presentation - June 2023 11
Slide 12: Healthcare capacity in Morocco and key dates
Private & public healthcare capacity in Morocco as of Number of beds per 1 000 people 1 2020 Private Casablanca - Settat 4,4 28% 18% Rabat-Salé-Kénitra 25% 2,8 Marrakech-Safi 2,2 37 388 8% 37 388 1,4 1,5 beds beds Fès-Meknès 1 8% 16% Oriental Public 11% Tanger-Tétouan- 72% 14% AlHoceima MENA** OECD
Slide 13: Health insurance coverage rollout
2021 2022 2023 CNSS CNOPS, 100% 100% 100% 14 14 14 mutual insurance million million million and private insurance 0% 100% 100% 11* 11 Ramedist Millions million 0% 32% 100% Self-employed 3,6 11 workers Millions million * December 2022 Investor Presentation - June 2023 13
Slide 14: Basic medical coverage: AMO and RAMED
Basic medical coverage Plans AMO RAMED Working people, retired people from Poor people not covered by a health insurance the public and private sectors and their plan dependents Beneficiaries Self-employed and independent professionals Former Resistance fighters Students State and local
Slide 15: Health cover and patient payment
Health cover Patient with a medical The patient pays the clinic directly and is reimbursed by care plan his or her medical insurance Remainder to Third The patient has state medical coverage before Taken be paid by party pay hospitalization or during his stay at 100% Ticket- Moderator The pati
Slide 16: Operational & financial performance
Operational & financial performance Présentation Investisseurs - Juin 2023 16
Slide 17: Operational capacity and admissions
Figures in M MAD Block 94 Operating rooms Chemotherapy 216 Chemotherapy chairs Catheterization room 29% 28% 10 Catheterization rooms 303 Radiotherapy 214 9 Accelerators 770 M MAD 1 035 MMAD in 2021 1% in 2022 2% Resuscitation 22 71% 6 175 Intensive care beds 69% 550 710 USI Diagnosis Multidisciplina
Slide 18: 2022 Key Figures: revenue, EBITDA, net income
2022 KEY FIGURES Figures in M MAD Revenue EBITDA Net income EBITDA margin Net margin 283 1.035 99 34,4% 51,8% 770 77,1% 186 56 27% 24% 10% 7% 2021 2022 2021 2022 2021 2022 Proforma Proforma Proforma Revenue: outstanding performance vs. 2021 Net income: outperformance of net income Full-year effect
Slide 19: EBITDA bridge 2022 vs. 2021
EBITDA BRIDGE 2022 vs. 2021 Figures in M MAD Investor Presentation - June 2023 19
Slide 20: 2022 Key Figures: fixed assets, net debt, equity
2022 KEY FIGURES Figures in M MAD Fixed assets** Net debt Shareholders' equity Net cash position Gearing 1.278 1.768 249 73,1% 587 191,6% - 43,7% 1.021 330 134% 438 26% -50 2021 2022 2021 2022 2021 2022 2021 2022 Proforma Proforma Proforma Proforma ** Non-current assets excluding goodwill, Investmen
Slide 21: Operating working capital requirement 2022 vs. 2021
Change in operating working capital requirement Figures in M MAD Operating WCR* 2022 vs. 2021 44 Stocks Customers Suppliers 447 57 385 246 22 223 15 155 -2 134 78 20 8 85 -5 2021 2022 2021 2022 2021 2022 PF 2021 2022 Number of days of Number of days of revenue revenue * Excluding items related to su
Slide 22: Revenue, EBITDA and net income 2019-2023p
Figures in M MAD Revenus EBITDA Net income 544 2.000 199 283 1.035 99 768 178 507 110 46 325 65 28 7 2019 2020 2021 2022 2023p 2019 2020 2021 2022 2023p 2019 2020 2021 2022 2023p Investor Presentation - June 2023 22
Slide 23: Outlook & strategic priorities
Outlook & strategic priorities Investor Presentation - June 2023 23
Slide 24: National geographic expansion
National geographic expansion Consolidation of the nationwide presence, with the opening of new establishments mainly in medium-sized cities Internationalization Diversification of the portfolio of treatment Development of strategic partnerships for Particularly in oncology, geriatrics, rehabilitati
Slide 25: Appendices
Appendices Investor Presentation - June 2023 25
Slide 26: Présentation Investisseurs - Juin 2023
Présentation Investisseurs - Juin 2023 26
Slide 27: Présentation Investisseurs - Juin 2023
Présentation Investisseurs - Juin 2023 27
Slide 28: Présentation Investisseurs - Juin 2023
Présentation Investisseurs - Juin 2023 28
Slide 29: Présentation Investisseurs - Juin 2023
Présentation Investisseurs - Juin 2023 29
Slide 30: Présentation Investisseurs - Juin 2023
Présentation Investisseurs - Juin 2023 30
Slide 31: Présentation Investisseurs - Juin 2023
Présentation Investisseurs - Juin 2023 31
Slide 32: Présentation Investisseurs - Juin 2023
Présentation Investisseurs - Juin 2023 32
Slide 33: Appendices
Appendices Investor Presentation - June 2023 33
Slide 34: Balance sheet
Balance sheet Dec 31, 21 Dec 31, 21 ASSETS 31-Dec-22 31-Dec-21 LIABILITIES 31-Dec-22 31-Dec-21 Pro forma Pro forma Fixed Assets Shareholder Equity 126 666 700 100 000 000 100 000 000 Merger, IPO issue, contribution Goodwill 22 473 241 26 224 004 27 559 254 984 826 370 247 273 063 247 273 063 premium
Slide 35: Income statement
Income statement 31-Dec-22 12/31/2021 Pro forma 31-Dec-21 Operating revenues 1 034 778 427 784 135 149 767 952 919 Revenues 1 034 777 927 770 026 130 767 620 277 Fixed Assets 500 14 109 019 332 642 Other revenues -857 307 675 -664 370 106 -656 551 226 Operating expenses -490 446 675 -385 515 399 -39
Slide 36: AKDITAL
(%) AKDITAL